Aktie A3CWBJ DA32 LIFE SCIENCE TECH ACQUISITION CORP.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen DA32 Life Science Tech Acquisition Corp.

Aktien

A3CWBJ

US23312M1062

DALS

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
DA32 Life Science Tech Acquisition Corp.(NasdaqCM:DALS) dropped from NASDAQ Composite Index
DA32 Life Science Tech Acquisition to Redeem All Shares
DA32 Life Science Tech Acquisition Corp. Announces Redemption of Shares
DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
DA32 LIFE SCIENCE TECH ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)
DA32 Life Science Tech Acquisition Corp. Auditor Raises 'Going Concern' Doubt
DA32 LIFE SCIENCE TECH ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
DA32 LIFE SCIENCE TECH ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
DA32 LIFE SCIENCE TECH ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
DA32 Life Science Tech Acquisition Corp. Reports Earnings Results for the Eight Months Ended December 31, 2021
DA32 LIFE SCIENCE TECH ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)
Certain Class B Common Stock of DA32 Life Science Tech Acquisition Corp. are subject to a Lock-Up Agreement Ending on 23-JAN-2022.
DA32 LIFE SCIENCE TECH ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
DA32 LIFE SCIENCE TECH ACQUISITION CORP. : Other Events (form 8-K)
DA32 Life Science Tech Acquisition Corp. : Sponsored by Deerfield, ARCH Venture Partners and Section 32, Announces Closing of $200 Million Initial Public Offering
DA32 LIFE SCIENCE TECH ACQUISITION CORP. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events (form 8-K)
DA32 Life Science Tech Acquisition Corp. Announces Executive Changes
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3CWBJ Aktie
  4. Nachrichten DA32 Life Science Tech Acquisition Corp.
  5. Andere Sprachen